{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:32:51Z","timestamp":1778859171170,"version":"3.51.4"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.vetimm.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,26]],"date-time":"2017-08-26T17:01:21Z","timestamp":1503766881000},"page":"80-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Type I interferons in the pathogenesis and treatment of canine diseases"],"prefix":"10.1016","volume":"191","author":[{"given":"Daniela","family":"Klotz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Baumg\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Gerhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2017.08.006_bib0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2011.06.069","article-title":"Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C","volume":"141","author":"Ahlenstiel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0010","doi-asserted-by":"crossref","first-page":"e74897","DOI":"10.1371\/journal.pone.0074897","article-title":"Anti-tumor effect of adipose tissue derived-mesenchymal stem cells expressing interferon-beta and treatment with cisplatin in a xenograft mouse model for canine melanoma","volume":"8","author":"Ahn","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10295-015-1677-7","article-title":"The biosynthetic pathway of FK506 and its engineering: from past achievements to future prospects","volume":"43","author":"Ban","year":"2016","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2008.09.023","article-title":"Pathogenesis and immunopathology of systemic and nervous canine distemper","volume":"127","author":"Beineke","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0025","doi-asserted-by":"crossref","first-page":"e25858","DOI":"10.1371\/journal.pone.0025858","article-title":"A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon","volume":"6","author":"Berger Rentsch","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2015.02.043","article-title":"Evaluation of the impact of neutralizing antibodies on IFNbeta response","volume":"449","author":"Bertolotto","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0035","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1073\/pnas.92.12.5645","article-title":"Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses","volume":"92","author":"Bluyssen","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.7326\/0003-4819-91-3-472","article-title":"Interferons: rationale for clinical trials in neoplastic disease","volume":"91","author":"Borden","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.1988.8.1","article-title":"The sensitivity of domestic animal cell lines to eight recombinant human interferons","volume":"8","author":"Bridgman","year":"1988","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/jir.1990.10.83","article-title":"Interferon treatment reduces endocytosis of virus and facultatively intracellular bacteria in various cell lines","volume":"10","author":"Bukholm","year":"1990","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0055","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1128\/JVI.00214-14","article-title":"Host and viral determinants of Mx2 antiretroviral activity","volume":"88","author":"Busnadiego","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-3164.2005.00466.x","article-title":"Multiple papillomavirus-associated epidermal hamartomas and squamous cell carcinomas in situ in a dog following chronic treatment with prednisone and cyclosporine","volume":"16","author":"Callan","year":"2005","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.25242","article-title":"Check your cultures! A list of cross-contaminated or misidentified cell lines","volume":"127","author":"Capes-Davis","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-3164.2009.00848.x","article-title":"The use of recombinant omega interferon therapy in canine atopic dermatitis: a double-blind controlled study","volume":"20","author":"Carlotti","year":"2009","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.it.2013.10.012","article-title":"Innate antiviral signalling in the central nervous system","volume":"35","author":"Carty","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0080","first-page":"283","article-title":"In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus","volume":"78","author":"Carvalho","year":"2014","journal-title":"Can. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0085","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1939-1676.2000.tb02262.x","article-title":"Treatment of canine hemangiosarcoma: 2000 and beyond","volume":"14","author":"Clifford","year":"2000","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/vr.152.4.105","article-title":"Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial","volume":"152","author":"de Mari","year":"2003","journal-title":"Vet. Rec."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/jcbfm.2013.227","article-title":"Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury","volume":"34","author":"de Rivero Vaccari","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0100","first-page":"175","article-title":"Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases","volume":"11","author":"Dec","year":"2008","journal-title":"Pol. J. Vet. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0105","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1073\/pnas.0602460103","article-title":"Neurons produce type I interferon during viral encephalitis","volume":"103","author":"Delhaye","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0110","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/JVI.02044-14","article-title":"Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon beta producers that protect from lethal encephalitis","volume":"89","author":"Detje","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0115","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4161\/viru.27902","article-title":"Mechanisms underlying the inhibition of interferon signaling by viruses","volume":"5","author":"Devasthanam","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0120","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1128\/JVI.02548-12","article-title":"TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation","volume":"87","author":"Di Pietro","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2011.02.023","article-title":"Antiviral activity of bovine type III interferon against foot-and-mouth disease virus","volume":"413","author":"Diaz-San Segundo","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0130","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/jir.2010.0078","article-title":"Interferon-lambda: a new addition to an old family","volume":"30","author":"Donnelly","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0135","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/ptr.5290","article-title":"Yu Ping Feng San, an ancient chinese herbal decoction, induces gene expression of anti-viral proteins and inhibits neuraminidase activity","volume":"29","author":"Du","year":"2015","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0140","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1089\/jir.2014.0009","article-title":"Functional characterization of canine interferon-lambda","volume":"34","author":"Fan","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0145","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biochi.2007.04.006","article-title":"Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use","volume":"89","author":"Ferrantini","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1073\/pnas.61.1.340","article-title":"Inducers of interferon and host resistance, V. In vitro studies","volume":"61","author":"Field","year":"1968","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.rvsc.2010.12.012","article-title":"Cytokine-enhanced vaccine and interferon-beta plus suicide gene as combined therapy for spontaneous canine sarcomas","volume":"91","author":"Finocchiaro","year":"2011","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-3164.2004.00363.x","article-title":"Immunomodulation and immunodeficiency","volume":"15","author":"Foster","year":"2004","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cytogfr.2015.01.001","article-title":"New perspectives on type I IFNs in cancer","volume":"26","author":"Gajewski","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0170","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1016\/j.vaccine.2010.03.062","article-title":"A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits","volume":"28","author":"Gao","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0175","first-page":"486","article-title":"Production of virus-induced and mitogen-induced interferons by canine cells","volume":"35","author":"Georgadze","year":"1990","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/jir.1985.5.403","article-title":"Pharmacokinetics of recombinant leukocyte A interferon following various routes and modes of administration to the dog","volume":"5","author":"Gibson","year":"1985","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0185","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/107999099313433","article-title":"Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjunctivitis sicca in dogs","volume":"19","author":"Gilger","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tim.2014.12.003","article-title":"Mx GTPases: dynamin-like antiviral machines of innate immunity","volume":"23","author":"Haller","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetimm.2006.08.013","article-title":"Revised nomenclature for veterinary allergy","volume":"114","author":"Halliwell","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0200","doi-asserted-by":"crossref","first-page":"e59892","DOI":"10.1371\/journal.pone.0059892","article-title":"High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7","volume":"8","author":"Hamamoto","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0205","first-page":"4749","article-title":"Pro-apoptotic and growth-inhibitory effect of IFN-beta-overexpressing canine adipose tissue-derived mesenchymal stem cells against melanoma cells","volume":"35","author":"Han","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0210","first-page":"158","article-title":"Fundamental studies on intravesical instillation of interferons in the treatment of bladder cancer","volume":"80","author":"Hara","year":"1989","journal-title":"Nihon Hinyokika Gakkai Zasshi. Jpn. J. Urol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0215","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ni.3180","article-title":"Interferon-lambda and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection","volume":"16","author":"Hernandez","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/jir.1987.7.173","article-title":"Structure and expression in Escherichia coli of canine interferon-alpha genes","volume":"7","author":"Himmler","year":"1987","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.immuni.2006.08.009","article-title":"Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors","volume":"25","author":"Honda","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0230","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/jir.1995.15.231","article-title":"Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected]","volume":"15","author":"Hu","year":"1995","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2172-11-22","article-title":"Global characterization of interferon regulatory factor (IRF) genes in vertebrates: glimpse of the diversification in evolution","volume":"11","author":"Huang","year":"2010","journal-title":"BMC. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vetimm.2013.09.013","article-title":"Antiviral and antiproliferative effects of canine interferon-lambda1","volume":"156","author":"Ichihashi","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0245","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1248\/cpb.38.549","article-title":"Intranasal administration of human fibroblast interferon in mice, rats, rabbits and dogs","volume":"38","author":"Igawa","year":"1990","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0250","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. Ser. B: Biol. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0255","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1098\/rspb.1957.0049","article-title":"Virus interference. II. Some properties of interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc. R. Soc. Lond. Ser. B: Biol. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0260","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1292\/jvms.60.911","article-title":"Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs","volume":"60","author":"Ishiwata","year":"1998","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0265","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1292\/jvms.09-0201","article-title":"Ability of orally administered IFN-alpha4 to inhibit naturally occurring gingival inflammation in dogs","volume":"72","author":"Ito","year":"2010","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0270","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0275","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1292\/jvms.58.23","article-title":"Cytopathic effect inhibition assay for canine interferon activity","volume":"58","author":"Iwata","year":"1996","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0280","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/jir.1996.16.765","article-title":"Cloning and expression of the canine interferon-beta gene","volume":"16","author":"Iwata","year":"1996","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0285","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1292\/jvms.66.721","article-title":"High level activity of 2\u2032,5\u2032-oligoadenylate synthetase in dog serum","volume":"66","author":"Iwata","year":"2004","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0290","first-page":"2092","article-title":"Neuroinflammation in advanced canine glaucoma","volume":"16","author":"Jiang","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0295","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1439-0442.1996.tb00493.x","article-title":"Effects of human interferons and 60 cobalt radiation on canine and feline tumour cells-preclinical studies","volume":"43","author":"Kessler","year":"1996","journal-title":"Zentralbl. Veterinarmed. A"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0300","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1097-2765(00)80013-1","article-title":"The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome","volume":"1","author":"Kim","year":"1997","journal-title":"Mol. Cell"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0378-1119(97)00240-0","article-title":"Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2","volume":"196","author":"Kim","year":"1997","journal-title":"Gene"},{"issue":"Pt. 3","key":"10.1016\/j.vetimm.2017.08.006_bib0310","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1099\/0022-1317-67-3-487","article-title":"In vitro and in vivo properties of the virus causing natural canine distemper encephalitis","volume":"67","author":"Kimoto","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0315","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.immuni.2010.06.016","article-title":"Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge","volume":"33","author":"Kohlmeier","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0320","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0325","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/jir.2012.0110","article-title":"Interferons as inducers of apoptosis in malignant cells","volume":"33","author":"Kotredes","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0330","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-2427(88)90106-7","article-title":"The effects of human interferon-alpha upon in vitro canine immune responses","volume":"19","author":"Krakowka","year":"1988","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0335","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1126\/science.169.3951.1213","article-title":"Tilorone hydrochloride: an orally active antiviral agent","volume":"169","author":"Krueger","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0340","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/jir.1994.14.57","article-title":"Cross-species antiviral and antiproliferative activity of human interferon-omega","volume":"14","author":"Kubes","year":"1994","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0345","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1348-0421.2006.tb03828.x","article-title":"Immunological effects of recombinant feline interferon-omega (KT-80) administration in the dog","volume":"50","author":"Kuwabara","year":"2006","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0350","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/cmi.2010.25","article-title":"Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction","volume":"7","author":"Law","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0355","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cyto.2013.12.001","article-title":"Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega","volume":"66","author":"Litzlbauer","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0360","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vetimm.2013.02.001","article-title":"Canine keratinocytes upregulate type I interferons and proinflammatory cytokines in response to poly(dA:dT) but not to canine papillomavirus","volume":"153","author":"Luff","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0365","doi-asserted-by":"crossref","first-page":"e102033","DOI":"10.1371\/journal.pone.0102033","article-title":"Keratinocyte antiviral response to Poly(dA:dT) stimulation and papillomavirus infection in a canine model of X-linked severe combined immunodeficiency","volume":"9","author":"Luff","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0370","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2174\/092986707780597907","article-title":"Interferon: cellular executioner or white knight?","volume":"14","author":"Maher","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0375","first-page":"257","article-title":"Inhalation route for administration of systemic drugs","volume":"14","author":"Mallet","year":"1997","journal-title":"Rev. Mal. Respir."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0380","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-1135(02)00173-6","article-title":"Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial","volume":"89","author":"Martin","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0385","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jbspin.2009.03.012","article-title":"Interferons and autoimmune disorders","volume":"76","author":"Meyer","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0390","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-1135(99)00087-5","article-title":"Feline interferon-omega treatment on canine parvovirus infection","volume":"69","author":"Minagawa","year":"1999","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0395","doi-asserted-by":"crossref","first-page":"e103249","DOI":"10.1371\/journal.pone.0103249","article-title":"MDSCs mediate angiogenesis and predispose canine mammary tumor cells for metastasis via IL-28\/IL-28RA (IFN-lambda) signaling","volume":"9","author":"Mucha","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0400","first-page":"1700","article-title":"Immunizing property of vaccinia virus inactivated by ultraviolets rays","volume":"148","author":"Nagano","year":"1954","journal-title":"C. R. Seances Soc. Biol. Fil."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0405","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0145-305X(80)80056-5","article-title":"Restoration of antibody forming capacity in early-thymectomized Xenopus by injecting thymocytes","volume":"4","author":"Nagata","year":"1980","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0410","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/jir.2005.25.169","article-title":"Intracellular localization and antiviral property of canine Mx proteins","volume":"25","author":"Nakamura","year":"2005","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0415","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(99)01785-8","article-title":"Expression of canine interferon-beta by a recombinant vaccinia virus","volume":"466","author":"Nishikawa","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0420","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1292\/jvms.63.445","article-title":"Comparison of the growth inhibitory effects of canine IFN-alpha, \u2212beta and \u2212gamma on canine cells infected with Neospora caninum tachyzoites","volume":"63","author":"Nishikawa","year":"2001","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0425","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-3164.2012.01088.x","article-title":"A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008\u20132011 update","volume":"24","author":"Olivry","year":"2013","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0430","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12917-015-0514-6","article-title":"Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA)","volume":"11","author":"Olivry","year":"2015","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0435","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1128\/JVI.77.13.7635-7644.2003","article-title":"STAT protein interference and suppression of cytokine signal transduction by measles virus V protein","volume":"77","author":"Palosaari","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0440","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00705-015-2395-1","article-title":"Analysis of cytokine production in a newly developed canine tracheal epithelial cell line infected with H3N2 canine influenza virus","volume":"160","author":"Park","year":"2015","journal-title":"Arch. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0445","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1476-5829.2009.00192.x","article-title":"Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours","volume":"7","author":"Penzo","year":"2009","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0450","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00239-006-0073-3","article-title":"The mammalian 2\u2032-5\u2032 oligoadenylate synthetase gene family: evidence for concerted evolution of paralogous Oas1 genes in Rodentia and Artiodactyla","volume":"63","author":"Perelygin","year":"2006","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0455","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/jcmm.13023","article-title":"Reduced angiogenic gene expression in morbillivirus-triggered oncolysis in a translational model for histiocytic sarcoma","volume":"21","author":"Pfankuche","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0460","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.vetimm.2012.06.003","article-title":"Gene transcription abnormalities in canine atopic dermatitis and related human eosinophilic allergic diseases","volume":"149","author":"Plager","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0465","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1354\/vp.43-6-981","article-title":"Immunohistochemical evaluation of mx protein expression in canine encephalitides","volume":"43","author":"Porter","year":"2006","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0470","first-page":"67","article-title":"Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro","volume":"59","author":"Priosoeryanto","year":"1995","journal-title":"Can. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0475","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1128\/JVI.01878-09","article-title":"Two domains of the V protein of virulent canine distemper virus selectively inhibit STAT1 and STAT2 nuclear import","volume":"84","author":"R\u00f6thlisberger","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0480","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3109\/08916930903510880","article-title":"Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity","volume":"43","author":"Rizza","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0485","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biopha.2015.04.002","article-title":"Interferon-beta gene transfer induces a strong cytotoxic bystander effect on melanoma cells","volume":"72","author":"Rossi","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0490","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1292\/jvms.68.1347","article-title":"High level expression of biologically active canine interferon-alpha subtype 4 using a baculovirus","volume":"68","author":"Ruttanapumma","year":"2006","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0495","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0500","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0038-1632973","article-title":"Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and synovial fluid of osteoarthritic dogs","volume":"19","author":"Salinardi","year":"2006","journal-title":"Vet. Comp. Orthop. Traumatol.: V.C.O.T"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0505","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jid.2016.03.015","article-title":"Canine and human atopic dermatitis: two faces of the same host-microbe interaction","volume":"136","author":"Santoro","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0510","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tvjl.2015.09.016","article-title":"An update on the treatment of canine atopic dermatitis","volume":"207","author":"Saridomichelakis","year":"2016","journal-title":"Vet. J."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0515","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-5793(98)01514-2","article-title":"Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7","volume":"441","author":"Sato","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0520","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1074\/jbc.273.5.2714","article-title":"Regulation of type I interferon gene expression by interferon regulatory factor-3","volume":"273","author":"Schafer","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0525","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0530","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1099\/vir.0.020370-0","article-title":"High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state","volume":"91","author":"Seitz","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0535","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0540","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1186\/s12864-015-2036-9","article-title":"High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells","volume":"16","author":"Shukla","year":"2015","journal-title":"BMC Genom."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0545","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2460\/ajvr.1980.41.11.1833","article-title":"Minimal interferon induction in dogs, using a modified polyriboinosinic-polyribocytidylic acid complex","volume":"41","author":"Smith","year":"1980","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0550","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.vetimm.2012.04.005","article-title":"The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases","volume":"147","author":"Spitzbarth","year":"2012","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0555","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1074\/jbc.C109.095703","article-title":"Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins","volume":"285","author":"Sridharan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0560","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5326\/0400411","article-title":"Pigmented epidermal plaques in three dogs","volume":"40","author":"Stokking","year":"2004","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0565","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fmicb.2015.00228","article-title":"Global and quantitative proteomic analysis of dogs infected by avian-like H3N2 canine influenza virus","volume":"6","author":"Su","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0570","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1099\/jgv.0.000322","article-title":"Identification of the IFN-beta response in H3N2 canine influenza virus infection","volume":"97","author":"Su","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0575","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/JVI.03076-13","article-title":"Morbillivirus control of the interferon response: relevance of STAT2 and mda5 but not STAT1 for canine distemper virus virulence in ferrets","volume":"88","author":"Svitek","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0580","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1292\/jvms.67.1059","article-title":"Cloning and expression of canine interferon-alpha genes in Escherichia coli","volume":"67","author":"Taira","year":"2005","journal-title":"J. Vet. Med. Sci.e"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0585","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01850","article-title":"Integration of interferon-alpha\/beta signalling to p53 responses in tumour suppression and antiviral defence","volume":"424","author":"Takaoka","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0590","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0034-5288(95)90017-9","article-title":"In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours","volume":"59","author":"Tateyama","year":"1995","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0595","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.icb.7100100","article-title":"Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response","volume":"85","author":"Thompson","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0600","first-page":"75","article-title":"Human recombinant interferon alpha-2b for management of idiopathic recurrent superficial pyoderma in dogs: a pilot study","volume":"5","author":"Thompson","year":"2004","journal-title":"Vet. Ther.: Res. Appl. Vet. Med."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0605","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/107999099313325","article-title":"Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action","volume":"19","author":"Tompkins","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0610","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2460\/javma.246.6.613","article-title":"Pathology in practice: canine distemper virus disease in a dog","volume":"246","author":"Townsell","year":"2015","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0615","first-page":"1","article-title":"The interferons","volume":"54","author":"Toy","year":"1983","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0620","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2460\/ajvr.1979.40.03.356","article-title":"Interferon induction in dogs","volume":"40","author":"Tsai","year":"1979","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0625","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2460\/ajvr.1983.44.08.1588","article-title":"Virus-induced interferon production in canine lymphoid cell cultures","volume":"44","author":"Tsai","year":"1983","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0630","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01315222","article-title":"Interferon in cerebrospinal fluid: a marker for viral persistence of canine distemper encephalomyelitis","volume":"72","author":"Tsai","year":"1982","journal-title":"Arch. Virol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0635","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3748\/wjg.v17.i4.419","article-title":"Peginterferon and ribavirin treatment for hepatitis C virus infection","volume":"17","author":"Tsubota","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0640","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5326\/0440276","article-title":"Use of recombinant human interferon alpha-2a in the management of a dog with epitheliotropic lymphoma","volume":"44","author":"Tzannes","year":"2008","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0645","doi-asserted-by":"crossref","first-page":"e95917","DOI":"10.1371\/journal.pone.0095917","article-title":"Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination","volume":"9","author":"Ulrich","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0650","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clineuro.2010.03.010","article-title":"Therapy of MS","volume":"112","author":"Vosoughi","year":"2010","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0655","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.virol.2014.09.010","article-title":"Recombinant rabies virus expressing IFNalpha1 enhanced immune responses resulting in its attenuation and stronger immunogenicity","volume":"468\u2013470","author":"Wang","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0660","first-page":"47","article-title":"Prolongation of allografts in animals with a new agent: tilorone","volume":"5","author":"Wildstein","year":"1975","journal-title":"Proc. Clin. Dial. Transplant Forum"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0665","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/gene.2009.72","article-title":"Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines","volume":"10","author":"Witte","year":"2009","journal-title":"Genes Immun."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0670","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gene.2007.03.018","article-title":"Evolution of the interferon alpha gene family in eutherian mammals","volume":"397","author":"Woelk","year":"2007","journal-title":"Gene"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0675","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2133\/dmpk.25.149","article-title":"Co-administration of tacrolimus suppresses pharmacokinetic modulation of multiple subcutaneously administered human interferon-alpha in Beagle dogs","volume":"25","author":"Yamazaki","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0680","first-page":"807","article-title":"Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, \u2212lambda2 and \u2212lambda3","volume":"25","author":"Yang","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0685","first-page":"299","article-title":"Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction","volume":"25","author":"Yang","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0690","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/jir.2013.0037","article-title":"Molecular and functional characterization of canine interferon-epsilon","volume":"33","author":"Yang","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0695","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pep.2015.07.007","article-title":"Expression and purification of Canis interferon alpha in Escherichia coli using different tags","volume":"115","author":"Yang","year":"2015","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0700","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1038\/ncomms5963","article-title":"Primate-specific miR-576-3p sets host defense signalling threshold","volume":"5","author":"Yarbrough","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0705","doi-asserted-by":"crossref","first-page":"13108","DOI":"10.1073\/pnas.96.23.13108","article-title":"Mechanism by which the IFN-beta enhanceosome activates transcription","volume":"96","author":"Yie","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetimm.2017.08.006_bib0710","first-page":"216","article-title":"A field trial of recombinant human interferon alpha-2b for nasal spray to prevent SARS and other respiratory viral infections","volume":"19","author":"Yu","year":"2005","journal-title":"Zhonghua shi yan he lin chuang bing du xue za zhi"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0715","doi-asserted-by":"crossref","first-page":"21458","DOI":"10.3390\/molecules201219781","article-title":"An effective synthesis method for tilorone dihydrochloride with obvious IFN-alpha inducing activity","volume":"20","author":"Zhang","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.vetimm.2017.08.006_bib0720","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbrc.2014.10.067","article-title":"Type I interferon-mediated immune response against influenza A virus is attenuated in the absence of p53","volume":"454","author":"Zhu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242717303264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242717303264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T03:34:13Z","timestamp":1750822453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242717303264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":144,"alternative-id":["S0165242717303264"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2017.08.006","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I interferons in the pathogenesis and treatment of canine diseases","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}